# Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients With Peritoneal Metastases From Colorectal Cancer

> **NCT06269978** · PHASE1 · RECRUITING · sponsor: **Arjun Mittra** · enrollment: 24 (estimated)

## Conditions studied

- Metastatic Colorectal Carcinoma
- Metastatic Malignant Neoplasm in the Peritoneum
- Stage IV Colorectal Cancer AJCC v8

## Interventions

- **PROCEDURE:** Biopsy
- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Diagnostic Laparoscopy
- **DRUG:** Fluorouracil
- **PROCEDURE:** Magnetic Resonance Imaging
- **DRUG:** Oxaliplatin
- **PROCEDURE:** Surgical Procedure

## Key facts

- **NCT ID:** NCT06269978
- **Lead sponsor:** Arjun Mittra
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-31
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-03-10

## Collaborators

- National Cancer Institute (NCI)

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06269978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06269978, "Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients With Peritoneal Metastases From Colorectal Cancer". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT06269978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*